Full name
NU-MED CENTRUM DIAGNOSTYKI I TERAPII ONKOLOGICZNEJ KATOWICE SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
86.10.Z - Hospital activities
47.74.Z - Retail sale of medical and orthopedic products
64.92.Z - Other forms of credit granting
64.99.Z - Other financial services, except insurance and pension funds, not elsewhere classified
68.20.Z - Rental and management of own or leased real estate
85.60.Z - Educational support activities
86.21.Z - General medical practice
86.22.Z - Specialist medical practice
86.90.C - Healthcare
86.90.E - Healthcare
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | -2,8 | 0,8 | 6,9 | 803,1 |
EBITDA | -1,3 | 2,2 | 7,9 | 265,5 |
Short time liabilities | 51,7 | 24,2 | 5,4 | -77,8 |
Equity capital | -27,7 | -26,2 | -20,7 | 20,9 |
Operating profit (EBIT) | 3,4 | 7 | 12,7 | 81,4 |
Assets | 31,7 | 30,5 | 37,8 | 23,6 |
Net profit (loss) | -6,2 | 1,5 | 5,5 | 259,3 |
Cash | 0 | 1,6 | 2,1 | 25,2 |
Net income from sale | 21,6 | 29,2 | 40,1 | 37,5 |
Liabilities and provisions for liabilities | 59,4 | 56,8 | 58,5 | 3 |
Working assets | 9,6 | 10,5 | 11,5 | 9,1 |
Depreciation | -4,7 | -4,9 | -4,8 | 0,8 |
% | % | % | p.p. | |
Profitability of capital | 22,3 | -5,8 | -26,4 | -20,6 |
Equity capital to total assets | -87,6 | -85,8 | -54,9 | 30,9 |
Gross profit margin | -13 | 2,6 | 17,3 | 14,7 |
EBITDA Margin | -5,8 | 7,4 | 19,7 | 12,3 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 875 | 302 | 49 | -253 |
Current financial liquidity indicator | 0.18445715308189392 | 0.4316026270389557 | 2.1092846393585205 | 1,7 |
Net dept to EBITDA | -41.78081130981445 | 22.835580825805664 | 6.114743232727051 | -16,7 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane